Decline depth
-40.7%
From rolling 252-day high of $59.83, 115d ago.
Past the 40% Red List threshold.
Red List
PAHCPhibro Animal Health Corporatio
Healthcare · Drug Manufacturers - Specialty & Generic · small-cap ($1.5B)
-40.7%
from rolling 252-day high of $59.83 set 2026-04-13 · 115d ago
Current
$35.50
Decline depth
-40.7%
Decline σ
3.4σ
TFC
0/5 bearish
Rolling 252-day high
Up day
Down day
Last 90 trading days · data from Alpaca
Since it joined the list
$PAHC landed on the list 2026-05-11, down 39.5% from its 52-week high that day — now down -40.7%.
That's 3.1 percentage points deeper than the day it joined. It bottomed 52.5% below that high along the way.
Decline from the 52-week high as it stood on 2026-05-11 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.
Structural break signals
PAHC qualifies for the Red List on decline depth.
Time-frame continuity
0/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3.
Decline sigma
3.4σ
Drop from local high over the last 10 bars, expressed in units of the stock's typical daily volatility (1.96% per day).
The structural read
What price action says about PAHC.
PAHC qualifies for the Red List on decline depth — down -40.7% from its rolling 252-day high. Past the 40% threshold, the deepest tier in the taxonomy. Depth plus recency: this is the pattern many investors call a falling knife.
Upstream TFC read: bearish alignment, current phase daily. Last bar types — daily 1 (red), weekly 1 (red), monthly 1 (red).
Earnings on file: 2026-05-06. Tiering is unaffected by earnings dates — listings reflect price structure only.
Questions about PAHC
What people ask.
Why is PAHC on Broken Stocks?
PAHC qualifies for the Red List on decline depth. It is down -40.7% from its rolling 252-day high of $59.83, set on 2026-04-13 — 115d ago.
Is PAHC a falling knife?
By the most common technical definition — a steep, recent breakdown from a fresh high — yes. PAHC is down -40.7% from its 52-week high of $59.83, set 115d ago. That combination of depth (past the 30% Amber threshold) and recency (high set inside the last 120 days) is the textbook falling-knife pattern. Whether to try to catch it is a separate question — historically most attempts to bottom-pick continue lower before reversing. Broken Stocks flags the pattern; it does not recommend buying or selling.
Is PAHC a buy?
Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.
Where is PAHC trading inside its 52-week range?
At $35.50, PAHC sits 28.8% of the way from its 52-week low ($25.58) to its 52-week high ($60.08). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.
How fast has PAHC been declining?
The current 40.7% decline accrued over 115d, which annualizes to roughly -129.2% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.
How does PAHC compare to its sector?
There are 153 other Healthcare tickers on Broken Stocks: 75 Red, 37 Amber, 41 Watch, with 74 showing recovering structural signals. Median sector decline is -35.3% — PAHC's decline is deeper than the sector median.
Does PAHC's earnings date affect its tier?
No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-06) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.